UNICHEM LABORATORIES Financial Statement Analysis
|
||
|
The Revenues of UNICHEM LABORATORIES have decreased by -98.67% YoY .
The Earnings Per Share (EPS) of UNICHEM LABORATORIES has increased by Positive YoY. |
||
UNICHEM LABORATORIES Last 5 Annual Financial Results
[BOM: 506690|NSE : UNICHEMLAB]
| Consolidated | Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 |
|---|---|---|---|---|---|
| Revenues | ₹1,785 Cr | ₹134,302 Cr | ₹1,270 Cr | ₹1,235 Cr | ₹1,104 Cr |
| Expenses | ₹1,698 Cr | ₹138,858 Cr | ₹1,197 Cr | ₹1,144 Cr | ₹1,155 Cr |
| Operating Profit (Excl OI) | ₹87 Cr | ₹-4,556 Cr | ₹73 Cr | ₹91 Cr | ₹-51 Cr |
| Other Income | ₹32 Cr | ₹3,852 Cr | ₹48 Cr | ₹50 Cr | ₹91 Cr |
| Interest | ₹23 Cr | ₹1,731 Cr | ₹6.11 Cr | ₹5.12 Cr | ₹7.85 Cr |
| Depreciation | ₹123 Cr | ₹11,344 Cr | ₹91 Cr | ₹84 Cr | ₹82 Cr |
| Profit Before Tax | ₹-85 Cr | ₹-17,636 Cr | ₹22 Cr | ₹51 Cr | ₹-48 Cr |
| Profit After Tax | ₹-94 Cr | ₹-20,223 Cr | ₹33 Cr | ₹34 Cr | ₹-60 Cr |
| Consolidated Net Profit | ₹-94 Cr | ₹-20,223 Cr | ₹33 Cr | ₹34 Cr | ₹-60 Cr |
| Earnings Per Share (Rs) | ₹19.53 | ₹-13.32 | ₹-28.72 | ₹4.70 | ₹4.88 |
| PAT Margin (%) | 6.51 | -5.25 | -15.06 | 2.60 | 2.78 |
| ROE(%) | 5.64 | -3.86 | -8.04 | 1.28 | 1.35 |
| ROCE(%) | 6.34 | -2.31 | -5.60 | 1.00 | 2.11 |
| Total Debt/Equity(x) | 0.18 | 0.09 | 0.12 | 0.13 | 0.04 |
Key Financials |
||
| Market Cap | : | ₹ 2,625.6 Cr |
| Revenue (TTM) | : | ₹ 2,213.9 Cr |
| Net Profit(TTM) | : | ₹ 294.9 Cr |
| EPS (TTM) | : | ₹ 41.9 |
| P/E (TTM) | : | 8.9 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| UNICHEM LABORATORIES | -3.6% | -6.5% | -47.7% |
| SUN PHARMACEUTICAL INDUSTRIES | 0.4% | 2.6% | NA |
| DIVIS LABORATORIES | -4.5% | 0.7% | 3.4% |
| CIPLA | -0.5% | -3.4% | -6.7% |
| TORRENT PHARMACEUTICALS | 5% | 4.1% | 37.2% |
| DR REDDYS LABORATORIES | 1.2% | 10.2% | 4.8% |
| MANKIND PHARMA | -1.1% | -2.6% | -15.1% |
| ZYDUS LIFESCIENCES | 1% | 2.9% | -3.4% |
| LUPIN | 1.8% | 3.2% | 7.5% |
UNICHEM LABORATORIES Revenues
[BOM: 506690|NSE : UNICHEMLAB]
| Y-o-Y | -98.67 % |
| 5 Yr CAGR | 12.77 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,785 Cr | -98.67 | |
| Mar2024 | ₹134,302 Cr | 10,476.38 | |
| Mar2023 | ₹1,270 Cr | 2.81 | |
| Mar2022 | ₹1,235 Cr | 11.91 | |
| Mar2021 | ₹1,104 Cr | - | |
UNICHEM LABORATORIES Operating Profit
[BOM: 506690|NSE : UNICHEMLAB]
| Y-o-Y | Positive |
| 5 Yr CAGR | Positive |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹87 Cr | Positive | |
| Mar2024 | ₹-4,556 Cr | Negative | |
| Mar2023 | ₹73 Cr | -20.10 | |
| Mar2022 | ₹91 Cr | Positive | |
| Mar2021 | ₹-51 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | Positive |
| 5 Yr CAGR | Positive |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2025 | 4.87% | Positive | |
| Mar2024 | -3.39% | Negative | |
| Mar2023 | 5.73% | -22.36 | |
| Mar2022 | 7.38% | Positive | |
| Mar2021 | -4.6% | - | |
UNICHEM LABORATORIES Profit After Tax
[BOM: 506690|NSE : UNICHEMLAB]
| Y-o-Y | Negative |
| 5 Yr CAGR | Negative |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹-94 Cr | Negative | |
| Mar2024 | ₹-20,223 Cr | Negative | |
| Mar2023 | ₹33 Cr | -3.68 | |
| Mar2022 | ₹34 Cr | Positive | |
| Mar2021 | ₹-60 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | Positive |
| 5 Yr CAGR | 23.70 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2025 | 6.51 % | Positive | |
| Mar2024 | -5.25 % | Negative | |
| Mar2023 | -15.06 % | Negative | |
| Mar2022 | 2.6 % | -6.47 | |
| Mar2021 | 2.78 % | - | |
UNICHEM LABORATORIES Earnings Per Share (EPS)
[BOM: 506690|NSE : UNICHEMLAB]
| Y-o-Y | Positive |
| 5 Yr CAGR | 41.44 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2025 | ₹20 | Positive | |
| Mar2024 | ₹-13 | Negative | |
| Mar2023 | ₹-29 | Negative | |
| Mar2022 | ₹4.70 | -3.69 | |
| Mar2021 | ₹4.88 | - | |
UNICHEM LABORATORIES Return on Capital Employed (ROCE)
[BOM: 506690|NSE : UNICHEMLAB]
| Y-o-Y | Positive |
| 5 Yr CAGR | 31.66 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2025 | 6.34% | Positive | |
| Mar2024 | -2.31% | Negative | |
| Mar2023 | -5.6% | Negative | |
| Mar2022 | 1% | -52.61 | |
| Mar2021 | 2.11% | - | |
UNICHEM LABORATORIES Share Price vs Sensex
| Current Share Price | : | ₹373.0 |
| Current MarketCap | : | ₹ 2,625.6 Cr |
| Updated EOD on | : | Feb 17,2026 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| UNICHEM LABORATORIES | -3.6% |
-6.5% |
-47.7% |
| SENSEX | -1% |
-0.1% |
7.9% |
UNICHEM LABORATORIES related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE ALLCAP | 6.4% | 8.9% | 7.5% |
| BSE MIDSMALLCAP | 4.7% | 9% | 8.4% |
| BSE HEALTHCARE | 1.4% | 0.8% | 2.4% |
| BSE SMALLCAP | -5.8% | -8.9% | -10.5% |
No NSE index found
You may also like the below Video Courses
FAQ about UNICHEM LABORATORIES Financials
How the annual revenues of UNICHEM LABORATORIES have changed ?
The Revenues of UNICHEM LABORATORIES have decreased by -98.67% YoY .
How the Earnings per Share (EPS) of UNICHEM LABORATORIES have changed?
The Earnings Per Share (EPS) of UNICHEM LABORATORIES has increased by Positive YoY .
Check out Intrinsic Value of Peers of UNICHEM LABORATORIES
Compare Stock Analytics of Peers of UNICHEM LABORATORIES
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs
